These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1562 related items for PubMed ID: 16111817

  • 1. Excitotoxic brain damage involves early peroxynitrite formation in a model of Huntington's disease in rats: protective role of iron porphyrinate 5,10,15,20-tetrakis (4-sulfonatophenyl)porphyrinate iron (III).
    Pérez-De La Cruz V, González-Cortés C, Galván-Arzate S, Medina-Campos ON, Pérez-Severiano F, Ali SF, Pedraza-Chaverrí J, Santamaría A.
    Neuroscience; 2005; 135(2):463-74. PubMed ID: 16111817
    [Abstract] [Full Text] [Related]

  • 2. Iron porphyrinate Fe(TPPS) reduces brain cell damage in rats intrastriatally lesioned by quinolinate.
    González-Cortés C, Salinas-Lara C, Gómez-López MA, Tena-Suck ML, Pérez-De La Cruz V, Rembao-Bojórquez D, Pedraza-Chaverrí J, Gómez-Ruiz C, Galván-Arzate S, Ali SF, Santamaría A.
    Neurotoxicol Teratol; 2008; 30(6):510-9. PubMed ID: 18579343
    [Abstract] [Full Text] [Related]

  • 3. Targeting oxidative/nitrergic stress ameliorates motor impairment, and attenuates synaptic mitochondrial dysfunction and lipid peroxidation in two models of Huntington's disease.
    Pérez-De La Cruz V, Elinos-Calderón D, Robledo-Arratia Y, Medina-Campos ON, Pedraza-Chaverrí J, Ali SF, Santamaría A.
    Behav Brain Res; 2009 May 16; 199(2):210-7. PubMed ID: 19100293
    [Abstract] [Full Text] [Related]

  • 4. NAD(P)H oxidase contributes to neurotoxicity in an excitotoxic/prooxidant model of Huntington's disease in rats: protective role of apocynin.
    Maldonado PD, Molina-Jijón E, Villeda-Hernández J, Galván-Arzate S, Santamaría A, Pedraza-Chaverrí J.
    J Neurosci Res; 2010 Feb 15; 88(3):620-9. PubMed ID: 19795371
    [Abstract] [Full Text] [Related]

  • 5. Contribution of nitric oxide, superoxide anion, and peroxynitrite to activation of mitochondrial apoptotic signaling in hippocampal CA3 subfield following experimental temporal lobe status epilepticus.
    Chuang YC, Chen SD, Liou CW, Lin TK, Chang WN, Chan SH, Chang AY.
    Epilepsia; 2009 Apr 15; 50(4):731-46. PubMed ID: 19178557
    [Abstract] [Full Text] [Related]

  • 6. S-Allylcysteine, a garlic-derived antioxidant, ameliorates quinolinic acid-induced neurotoxicity and oxidative damage in rats.
    Pérez-Severiano F, Rodríguez-Pérez M, Pedraza-Chaverrí J, Maldonado PD, Medina-Campos ON, Ortíz-Plata A, Sánchez-García A, Villeda-Hernández J, Galván-Arzate S, Aguilera P, Santamaría A.
    Neurochem Int; 2004 Dec 15; 45(8):1175-83. PubMed ID: 15380627
    [Abstract] [Full Text] [Related]

  • 7. Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: possible role of nitric oxide.
    Kumar P, Kumar A.
    Behav Brain Res; 2010 Jan 05; 206(1):38-46. PubMed ID: 19716383
    [Abstract] [Full Text] [Related]

  • 8. Blockade of quinolinic acid-induced neurotoxicity by pyruvate is associated with inhibition of glial activation in a model of Huntington's disease.
    Ryu JK, Kim SU, McLarnon JG.
    Exp Neurol; 2004 May 05; 187(1):150-9. PubMed ID: 15081596
    [Abstract] [Full Text] [Related]

  • 9. Excitotoxic damage, disrupted energy metabolism, and oxidative stress in the rat brain: antioxidant and neuroprotective effects of L-carnitine.
    Silva-Adaya D, Pérez-De La Cruz V, Herrera-Mundo MN, Mendoza-Macedo K, Villeda-Hernández J, Binienda Z, Ali SF, Santamaría A.
    J Neurochem; 2008 May 05; 105(3):677-89. PubMed ID: 18194214
    [Abstract] [Full Text] [Related]

  • 10. Neuroprotective effect of MK-801 against intra-striatal quinolinic acid induced behavioral, oxidative stress and cellular alterations in rats.
    Kalonia H, Kumar P, Nehru B, Kumar A.
    Indian J Exp Biol; 2009 Nov 05; 47(11):880-92. PubMed ID: 20099461
    [Abstract] [Full Text] [Related]

  • 11. Cytoplasmic calcium mediates oxidative damage in an excitotoxic /energetic deficit synergic model in rats.
    Pérez-De La Cruz V, Konigsberg M, Pedraza-Chaverri J, Herrera-Mundo N, Díaz-Muñoz M, Morán J, Fortoul-van der Goes T, Rondán-Zárate A, Maldonado PD, Ali SF, Santamaría A.
    Eur J Neurosci; 2008 Mar 05; 27(5):1075-85. PubMed ID: 18364032
    [Abstract] [Full Text] [Related]

  • 12. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
    Harris CA, Miranda AF, Tanguay JJ, Boegman RJ, Beninger RJ, Jhamandas K.
    Br J Pharmacol; 1998 May 05; 124(2):391-9. PubMed ID: 9641558
    [Abstract] [Full Text] [Related]

  • 13. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations.
    Kumar P, Kumar A.
    Eur J Pharmacol; 2009 Aug 01; 615(1-3):91-101. PubMed ID: 19445928
    [Abstract] [Full Text] [Related]

  • 14. Comparative neuroprotective profile of statins in quinolinic acid induced neurotoxicity in rats.
    Kalonia H, Kumar P, Kumar A.
    Behav Brain Res; 2011 Jan 01; 216(1):220-8. PubMed ID: 20696189
    [Abstract] [Full Text] [Related]

  • 15. Selenium reduces the proapoptotic signaling associated to NF-kappaB pathway and stimulates glutathione peroxidase activity during excitotoxic damage produced by quinolinate in rat corpus striatum.
    Santamaría A, Vázquez-Román B, La Cruz VP, González-Cortés C, Trejo-Solís MC, Galván-Arzate S, Jara-Prado A, Guevara-Fonseca J, Ali SF.
    Synapse; 2005 Dec 15; 58(4):258-66. PubMed ID: 16206188
    [Abstract] [Full Text] [Related]

  • 16. Tiagabine, a GABA uptake inhibitor, attenuates 3-nitropropionic acid-induced alterations in various behavioral and biochemical parameters in rats.
    Dhir A, Akula KK, Kulkarni SK.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr 01; 32(3):835-43. PubMed ID: 18234412
    [Abstract] [Full Text] [Related]

  • 17. Adenosine A2A receptor blockade before striatal excitotoxic lesions prevents long term behavioural disturbances in the quinolinic rat model of Huntington's disease.
    Scattoni ML, Valanzano A, Pezzola A, March ZD, Fusco FR, Popoli P, Calamandrei G.
    Behav Brain Res; 2007 Jan 25; 176(2):216-21. PubMed ID: 17123640
    [Abstract] [Full Text] [Related]

  • 18. Combined minocycline plus pyruvate treatment enhances effects of each agent to inhibit inflammation, oxidative damage, and neuronal loss in an excitotoxic animal model of Huntington's disease.
    Ryu JK, Choi HB, McLarnon JG.
    Neuroscience; 2006 Sep 15; 141(4):1835-48. PubMed ID: 16809003
    [Abstract] [Full Text] [Related]

  • 19. Probucol modulates oxidative stress and excitotoxicity in Huntington's disease models in vitro.
    Colle D, Hartwig JM, Soares FA, Farina M.
    Brain Res Bull; 2012 Mar 10; 87(4-5):397-405. PubMed ID: 22245028
    [Abstract] [Full Text] [Related]

  • 20. Attenuation of proinflammatory cytokines and apoptotic process by verapamil and diltiazem against quinolinic acid induced Huntington like alterations in rats.
    Kalonia H, Kumar P, Kumar A.
    Brain Res; 2011 Feb 04; 1372():115-26. PubMed ID: 21112316
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 79.